{"id":59,"date":"2018-05-14T16:16:41","date_gmt":"2018-05-14T13:16:41","guid":{"rendered":"http:\/\/www.mebid.org\/?p=59"},"modified":"2018-05-15T17:09:55","modified_gmt":"2018-05-15T14:09:55","slug":"biyoteknolojik-ilaclar-el-kitapcigi-ieis","status":"publish","type":"post","link":"https:\/\/www.mebid.org\/tr\/yayin\/biyoteknolojik-ilaclar-el-kitapcigi-ieis\/","title":{"rendered":"Biyoteknolojik ila\u00e7lar el kitap\u00e7\u0131\u011f\u0131 &#8211; \u0130E\u0130S"},"content":{"rendered":"<p>\u0130la\u00e7 \u0130\u015fverenler Enstit\u00fcs\u00fc taraf\u0131ndan haz\u0131rlanan Biyoteknolojik ila\u00e7lar el kitap\u00e7\u0131\u011f\u0131n\u0131 indirmek i\u00e7in <a href=\"http:\/\/www.ieis.org.tr\/ieis\/assets\/media\/Bio\/Biyoteknolojik_ilaclar_kitapcigi_.pdf\">t\u0131klay\u0131n\u0131z<\/a>.<\/p>\n<p>Biyoteknoloji, ila\u00e7 end\u00fcstrisinin insan sa\u011fl\u0131\u011f\u0131n\u0131n hizmetinde<br \/>\nilerlemesi i\u00e7in kilit \u00f6neme sahiptir. Bug\u00fcnk\u00fc \u015fartlarda bilinen<br \/>\nyakla\u015f\u0131k 30 bin hastal\u0131ktan ancak 10 bininin tedavisi yap\u0131labilmektedir.<br \/>\nHastal\u0131klara kar\u015f\u0131 yeni ila\u00e7lar\u0131n geli\u015ftirilmesinde biyoteknolojik y\u00f6ntemler<br \/>\ngiderek kimyasal ve bitkisel form\u00fclasyonlardan daha etkili olmaktad\u0131r.<br \/>\nSon y\u0131llarda ruhsatlanan yeni ila\u00e7lar aras\u0131nda biyoteknolojik ila\u00e7lar\u0131n oran\u0131<br \/>\ngiderek artmaktad\u0131r. Aralar\u0131nda kanser, alzheimer, kalp hastal\u0131klar\u0131, diyabet ve<br \/>\nromatoid artriti de i\u00e7eren 200 hastal\u0131\u011f\u0131n tedavisi i\u00e7in geli\u015ftirilen yeni ila\u00e7lar\u0131n<br \/>\nb\u00fcy\u00fck bir k\u0131sm\u0131n\u0131 biyoteknolojik ila\u00e7lar olu\u015fturmaktad\u0131r.<br \/>\n\u0130nsan sa\u011fl\u0131\u011f\u0131nda \u00e7\u0131\u011f\u0131r a\u00e7an biyoteknolojik \u00fcr\u00fcnler, \u00fcretim ve geli\u015ftirme<br \/>\nmaliyetlerinin y\u00fcksek olmas\u0131 nedeniyle pahal\u0131 \u00fcr\u00fcnlerdir.<br \/>\nBiyobenzer ila\u00e7lar, hem hastalar\u0131n biyoteknolojik ila\u00e7lara eri\u015fimini art\u0131rmakta<br \/>\nhem de rekabet yaratarak maliyetleri azaltmakta, sa\u011fl\u0131k sisteminin finansal<br \/>\ndevaml\u0131l\u0131\u011f\u0131na katk\u0131da bulunmaktad\u0131r. Ayr\u0131ca biyobenzer ila\u00e7lar\u0131n sat\u0131\u015fa<br \/>\nsunulmas\u0131 doktorlara ve hastalara yeni tedavi se\u00e7enekleri sunmaktad\u0131r.<\/p>\n<p>AB \u00fclkelerinin ulusal sa\u011fl\u0131k sistemleri,<br \/>\nyap\u0131lar\u0131 ve s\u00fcre\u00e7leri aras\u0131ndaki<br \/>\nfarkl\u0131l\u0131klar biyobenzer ila\u00e7lar\u0131n pazara<br \/>\ngirmesini etkilemektedir.<br \/>\nT\u00fcrkiye, k\u00fcresel ila\u00e7 end\u00fcstrisi i\u00e7in<br \/>\n\u00f6nemli merkezlerden<br \/>\nbirisidir. Ancak \u00fclkemizde biyobenzer<br \/>\n\u00fcr\u00fcnlerin \u00fcretiminin sadece belli<br \/>\na\u015famalar\u0131 yap\u0131labilmekte, biyoteknolojik<br \/>\nila\u00e7lar\u0131n b\u00fcy\u00fck bir k\u0131sm\u0131 ithal<br \/>\nedilmektedir. T\u00fcrkiye, her 1 kilogram<br \/>\nbiyoteknolojik ilaca ortalama<br \/>\n1 milyon dolar \u00f6demektedir.<br \/>\nBiyoteknolojik ila\u00e7lar\u0131n k\u00fcresel ila\u00e7<br \/>\npazar\u0131ndaki a\u011f\u0131rl\u0131\u011f\u0131n\u0131n art\u0131\u015f\u0131 ile birlikte<br \/>\nithalata ba\u011fl\u0131 bir biyoteknolojik<br \/>\nila\u00e7 tedarik modeli T\u00fcrkiye i\u00e7in<br \/>\ns\u00fcrd\u00fcr\u00fclebilir de\u011fildir ve yerli \u00fcretim ile<br \/>\ndesteklenmedi\u011fi takdirde T\u00fcrkiye\u2019nin<br \/>\nila\u00e7tan kaynaklanan cari a\u00e7\u0131\u011f\u0131n\u0131n<br \/>\nartaca\u011f\u0131 ortadad\u0131r.<\/p>\n<p>Biyobenzer \u00fcr\u00fcnlerin \u00fcretiminin t\u00fcm<br \/>\na\u015famalar\u0131 \u00fclkemizde ger\u00e7ekle\u015ftirilebilir.<br \/>\nBu \u00fcr\u00fcnlerin yurt i\u00e7inde \u00fcretiminin<br \/>\nsa\u011flanmas\u0131;<br \/>\n1- Bu pahal\u0131 teknolojinin \u00fclkemizde<br \/>\nolu\u015fmas\u0131,<br \/>\n2- Hastalar\u0131n biyoteknolojik \u00fcr\u00fcnlere<br \/>\neri\u015fiminin h\u0131zlanmas\u0131,<br \/>\n3- Hekimlere farkl\u0131 alternatifler<br \/>\nsunulmas\u0131,<br \/>\n4- \u0130la\u00e7 ithalat\u0131na ba\u011fl\u0131 d\u0131\u015f ticaret<br \/>\na\u00e7\u0131\u011f\u0131n\u0131n azalt\u0131lmas\u0131,<br \/>\n5- Yeni \u00fcr\u00fcnlerin pazara girmesi ile<br \/>\nolu\u015facak \u00fcr\u00fcn \u00e7e\u015fitlili\u011finin \u00fcr\u00fcn<br \/>\nfiyatlar\u0131n\u0131 a\u015fa\u011f\u0131ya \u00e7ekerek kamu<br \/>\nsa\u011fl\u0131k b\u00fct\u00e7elerinin daha verimli<br \/>\nkullan\u0131lmas\u0131,<br \/>\n6- Olu\u015facak rekabet ortam\u0131n\u0131n<br \/>\nara\u015ft\u0131rmac\u0131 \u015firketleri daha yenilik\u00e7i<br \/>\nila\u00e7 bulmaya y\u00f6nlendirmesi<br \/>\na\u00e7\u0131lar\u0131ndan b\u00fcy\u00fck \u00f6nem ta\u015f\u0131maktad\u0131r<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0130la\u00e7 \u0130\u015fverenler Enstit\u00fcs\u00fc taraf\u0131ndan haz\u0131rlanan Biyoteknolojik ila\u00e7lar el kitap\u00e7\u0131\u011f\u0131n\u0131 indirmek i\u00e7in t\u0131klay\u0131n\u0131z. Biyoteknoloji, ila\u00e7 end\u00fcstrisinin insan sa\u011fl\u0131\u011f\u0131n\u0131n hizmetinde ilerlemesi i\u00e7in kilit \u00f6neme sahiptir. Bug\u00fcnk\u00fc \u015fartlarda bilinen yakla\u015f\u0131k 30 bin hastal\u0131ktan ancak 10 bininin tedavisi yap\u0131labilmektedir. Hastal\u0131klara kar\u015f\u0131 yeni ila\u00e7lar\u0131n geli\u015ftirilmesinde biyoteknolojik y\u00f6ntemler giderek kimyasal ve bitkisel form\u00fclasyonlardan daha etkili olmaktad\u0131r. Son y\u0131llarda ruhsatlanan yeni ila\u00e7lar [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":164,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[5],"tags":[],"_links":{"self":[{"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/posts\/59\/"}],"collection":[{"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/posts\/"}],"about":[{"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/types\/post\/"}],"author":[{"embeddable":true,"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/users\/1\/"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/comments\/?post=59"}],"version-history":[{"count":1,"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/posts\/59\/revisions\/"}],"predecessor-version":[{"id":61,"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/posts\/59\/revisions\/61\/"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/media\/164\/"}],"wp:attachment":[{"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/media\/?parent=59"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/categories\/?post=59"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mebid.org\/tr\/wp-json\/wp\/v2\/tags\/?post=59"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}